A Study of OMP-336B11 in Subjects With Locally Advanced or Metastatic Tumors

NCT03295942 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

24

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Locally Advanced Malignant Neoplasm
Metastatic Cancer

Interventions

DRUG: OMP-336B11

Sponsor

OncoMed Pharmaceuticals, Inc.